In the article titled “UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells” [1], there is a concern of figure issue. In Figure 5(c), the wound healing images of PBS treatment were unintentionally misused for the control, siUBE2C, siUBE2C + ZEB1, and UBE2C treatments in the groups of 0 h. In addition, the wound healing image of siUBE2C treatment was unintentionally misused for the UBE2C + siZEB1 treatment in the groups of 36 h. The only change is in the panel of Figure 5(c), and the rest of the figure is identical to the published version. This unintentional error also has no bearing on the work’s scientific conclusions in any way. The authors apologize to the Editor of Journal of Oncology and to the readership for any inconvenience caused. The corrected figure and legend are presented here.
Corrigendum | Open Access
Corrigendum to “UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells”
Received22 Sept 2020
Accepted22 Sept 2020
Published20 Oct 2020
References
Y. Wu, D. Jin, X. Wang et al., “UBE2C induces cisplatin resistance via ZEB1/2-dependent upregulation of ABCG2 and ERCC1 in NSCLC cells,” Journal of Oncology, vol. 2019, Article ID 8607859, 15 pages, 2019.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2020 Yan Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.